[1] |
陈思, 刘华, 刘鷖雯, 等. 血清HER-2、CD44联合检测在结直肠癌中的临床价值[J]. 检验医学, 2022, 37(4):336-341.
DOI
URL
|
[2] |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
DOI
URL
|
[3] |
国家消化系统疾病临床医学研究中心上海, 国家消化道早癌防治中心联盟, 中华医学会消化内镜学分会, 等. 中国早期结直肠癌筛查流程专家共识意见(2019,上海)[J]. 中华消化内镜杂志, 2019, 36(10):709-719.
|
[4] |
朱赟洁, 马峥尧, 沈敏娜, 等. 结直肠癌患者血浆cfDNA检测方法的建立及临床应用评估[J]. 检验医学, 2022, 37(6):561-567.
DOI
URL
|
[5] |
DUAN S, HUANG W, LIU X, et al. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/Akt/ mTOR and PI3K/Akt/FOXO1 signaling pathways[J]. J Exp Clin Cancer Res, 2018, 37(1):304.
DOI
|
[6] |
WANG J, NISHIYAMA A, MATSUYAMA M, et al. The(pro) renin receptor:a novel biomarker and potential therapeutic target for various cancers[J]. Cell Commun Signal, 2020, 18(1):39.
DOI
URL
|
[7] |
XUE T, YANG J, SONG P, et al. Investigation on correlations of serum IL-26 with diagnosis and staging of gastric cancer[J]. JBUON, 2019, 24(1):215-220.
|
[8] |
FABBI M, CARBOTTI G, FERRINI S. Dual roles of IL-27 in cancer biology and immunotherapy[J]. Mediators Inflamm, 2017, 2017:3958069.
|
[9] |
WANG L, CHO K B, LI Y, et al. Long noncoding RNA(lncRNA)-mediated competing endogenous RNA net-works provide novel potential biomarkers and therapeutic targets for colorectal cancer[J]. Int J Mol Sci, 2019, 20(22):5758.
DOI
URL
|
[10] |
BALACESCU O, SUR D, CAINAP C, et al. The impact of miRNA in colorectal cancer progression and its liver metastases[J]. Int J Mol Sci, 2018, 19(12):3711.
DOI
URL
|
[11] |
PARSONS M J, KEELY S. FOXO3 loss drives inflammation associated CRC:the consequences of being(knock) out FOX'd[J]. Cell Mol Gastroenterol Hepatol, 2019, 7(2):295-296.
DOI
URL
|
[12] |
MOHAMMED A, YARLA N S, MADKA V, et al. Clinically relevant anti-inflammatory agents for chemoprevention of colorectal cancer:new perspectives[J]. Int J Mol Sci, 2018, 19(8):2332.
DOI
URL
|
[13] |
TU H, LAI X, LI J, et al. Interleukin-26 is overexpressed in human sepsis and contributes to inflammation,organ injury,and mortality in murine sepsis[J]. Crit Care, 2019, 23(1):290.
DOI
|
[14] |
ITOH T, HATANO R, KOMIYA E, et al. Biological effects of IL-26 on T cell-mediated skin inflammation,including psoriasis[J]. J Invest Dermatol, 2019, 139(4):878-889.
DOI
URL
|
[15] |
YOU W, TANG Q, ZHANG C, et al. IL-26 promotes the proliferation and survival of human gastric cancer cells by regulating the balance of STAT1 and STAT3 activation[J]. PLoS One, 2013, 8(5):e63588.
DOI
URL
|
[16] |
LAROCHETTE V, MIOT C, POLI C, et al. IL-26,a cytokine with roles in extracellular DNA-induced inflammation and microbial defense[J]. Front Immunol, 2019, 10:204.
DOI
URL
|
[17] |
万姗姗, 曹倩. Th17细胞在炎症性肠病发生过程中的效应应答[J]. 世界华人消化杂志, 2013(7):5.
|
[18] |
DANG A T, TELES R M, WEISS D I, et al. IL-26 contributes to host defense against intracellular bacteria[J]. J Clin Invest, 2019, 129(5):1926-1939.
DOI
PMID
|
[19] |
ZHU X, LIU Z, LIU J Q, et al. Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells[J]. J Leukoc Biol, 2016, 100(2):403-411.
DOI
URL
|
[20] |
ZHU J, LIU J Q, SHI M, et al. IL-27 gene therapy induces depletion of Tregs and enhances the efficacy of cancer immunotherapy[J]. JCI Insight, 2018, 3(7):e98745.
DOI
URL
|
[21] |
PARK Y J, RYU H, CHOI G, et al. IL-27 confers a protumor genic activity of regulatory T cells via CD39[J]. Proc Natl Acad Sci U S A, 2019, 116(8):3106-3111.
DOI
URL
|